GlassScriptPhysician profile
Diana Bisson Bragoli
NPI 1235499344
$2,764.82
in general payments reported to CMS, 2019-2025
21 companies · $480 in 2025
The $480 reported for 2025 was more than what a typical Adult Health (Nurse Practitioner) provider received nationally (typical 2025 total: $182).
See the full distribution for Adult Health (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $145 · 2022: $611 · 2023: $1,108 · 2024: $421 · 2025: $480.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,576 · Travel and Lodging: $433.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,576.08 |
| Travel and Lodging | $432.60 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Organogenesis INC. | $556.33 | 2021-2025 | Puraply, Affinity, Apligraf |
| Abiomed | $432.60 | 2023 | Impella |
| E.R. Squibb & Sons, L.L.C. | $264.72 | 2023-2024 | Eliquis, Camzyos |
| Paratek Pharmaceuticals, INC. | $244.70 | 2022-2023 | Nuzyra |
| Boehringer Ingelheim Pharmaceuticals, INC. | $238.28 | 2024-2025 | |
| Amgen INC. | $164.71 | 2022-2023 | Repatha |
| Avadel Cns Pharmaceuticals, LLC | $125.00 | 2025 | Lumryz |
| Astrazeneca Pharmaceuticals LP | $94.91 | 2024 | Fasenra |
| Smith+Nephew, INC. | $86.46 | 2021-2024 | Collagenase Santyl, Oasis, Stravix Pl |
| Bayer Healthcare Pharmaceuticals INC. | $86.37 | 2022 | |
| Biogen, INC. | $83.22 | 2022 | |
| Merck Sharp & Dohme LLC | $81.38 | 2023 | Verquvo |
| Mylan Specialty L.P. | $70.95 | 2022 | |
| Solventum Corporation | $70.85 | 2024-2025 | Activ.A.C., Promogran Prisma, Kerramax Care |
| Kci USA, INC. | $34.13 | 2021-2022 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bioventus LLC | $32.86 | 2022 | |
| Kerecis Limited | $25.46 | 2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Marigen, Kerecis Omega3 Graftguide |
| Integra Lifesciences Corporation | $22.87 | 2023 | Tcc-Ez |
| Convatec INC. | $20.85 | 2024 | |
| Tactile Systems Technology INC | $16.26 | 2021 | |
| Abbvie INC. | $11.91 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Diana Bragoli listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.